Nuriaea engleriana
Nuriaea engleriana · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Nuriaea engleriana is a botanical species currently being investigated for its significant bioactive potential. Through the use of aqueous and 80% methanolic extractions, researchers have isolated key chemical compounds including flavonoids and terpenoids. These extracts demonstrate potent antibacterial, antifungal, and antimicrobial activities against a variety of harmful pathogens. Specifically, the plant shows efficacy in combating challenging conditions such as MRSA, E. coli, Enterococcus faecalis, and Streptococcus pyogenes. Such findings highlight the importance of studying this plant as a potential source for new therapeutic agents.
- Synonyms
- Cirsium Englerianum
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Nuriaea engleriana is a botanical species that is frequently identified by its formal synonym, Cirsium englerianum. This taxonomic overlap can sometimes cause confusion for researchers and enthusiasts navigating various botanical databases. Understanding these nomenclature shifts is essential for maintaining accurate records within the study of plant evolution. Because the two names refer to the exact same organism, they are treated as interchangeable in most scientific contexts. Recognizing this relationship ensures that botanical literature remains consistent and reliable for the global scientific community.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Nuriaea engleriana is a specialized member of the kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It belongs to the order Asterales, which highlights its evolutionary connections to other flowering plants. Furthermore, the plant is situated within the diverse family Asteraceae. Ultimately, these botanical traits define its unique identity within the genus Nuriaea.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Nuriaea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Nuriaea engleriana is a distinct botanical species with a specialized geographical footprint. Its presence is primarily recorded across the vast continent of Africa, where it plays a role in local ecosystems. More specifically, the plant can be found throughout the Northeast Tropical Africa region. Within this area, Ethiopia serves as a key location for its documented distribution. Understanding these specific habitats is essential for studying the plant's environmental needs and survival.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Nuriaea engleriana, also identified as Cirsium englerianum, demonstrates significant therapeutic potential through its diverse biological activities. Research indicates that this medicinal plant possesses potent antibacterial properties, showing effectiveness against multidrug-resistant pathogens like MRSA and Streptococcus pyogenes. Furthermore, the plant exhibits notable antifungal effects, particularly against species such as C. albicans and T. mentagrophytes. These combined characteristics highlight its broad antimicrobial activity, making it a valuable subject for scientific study. Ultimately, the bioactive compounds found in the plant could serve as essential precursors for developing new antibiotics to combat resistant microbes.
Compounds
Nuriaea engleriana serves as a significant subject of interest within the study of medicinal plants used to treat urinary tract infections in Ethiopia. Phytochemical screening of this species has revealed a diverse chemical profile essential to its therapeutic potential. Specifically, the plant contains flavonoids, which contribute to its complex biological activity. Additionally, the presence of terpenoids further enhances its chemical makeup and medicinal value. These bioactive compounds underscore the plant's potential as a precursor for developing new antibiotic treatments.
Conditions
Nuriaea engleriana, referred to in the study as Cirsium englerianum, demonstrates significant antimicrobial efficacy against several multidrug-resistant pathogens. This plant effectively treats MRSA and Enterococcus faecalis, showing potent antibacterial activity against these specific microbes. Additionally, its extracts are capable of inhibiting the growth of E. coli and K. pneumoniae. Beyond its antibacterial properties, the plant also exhibits a remarkable antifungal effect against C. albicans. These diverse capabilities highlight its potential as a valuable source for developing new antimicrobial treatments.
Preparations
Nuriaea engleriana is prepared as extracts through specific laboratory processes to evaluate its medicinal properties. For these studies, 80% methanol was used for the extraction of the plant parts to isolate bioactive compounds. The preparation also involves both aqueous and 80% methanolic extraction methods to compare efficacy. These various extraction techniques are essential for screening the phytochemical constituents of the plant. Ultimately, the preparation of these extracts allows for the assessment of their antimicrobial activity against multidrug-resistant microbes.